logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yun Fan

cancer hospital of the university of chinese academy of sciences
H指数:28
被引数:2,798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study

在中国BRAFV600E突变转移性非小细胞肺癌患者中，encorafenib联合binimetinib的II期研究：OCEAN II研究的结果

Lung Cancer
IF4.4
2026-08-130
PRE
Huaqiang Zhou; Qing Zhou; Qisen Guo; Wei Guo; Gongyan Chen; Zhe Liu; Yun Fan; Yan Li; Yuh-Min Chen; Kenza Bouras; Laurence Del Frari; Angela Guo; Isabelle Klauck; Benoit Sansas; Li Zhang
Osimertinib with or without savolitinib as first-line treatment for MET-aberrant, EGFR-mutant NSCLC: randomized phase 2 trial (FLOWERS)

奥希替尼联合或不联合萨沃利替尼治疗MET异常、EGFR突变非小细胞肺癌的一线治疗：随机II期试验（FLOWERS）

Nature Communications
IF15.7
2026-01-130
OAAI
Anna Li; Wei-Neng Feng; Juan Li; Bing-Fei Xu; Jun Zhao; Yun Jia; Ke-Jing Tang; Yong-Sheng Li; Cheng-Zhi Zhou; Yun Fan; Chong-Rui Xu; Yue-Li Sun; Hua-Jun Chen; Hong-Hong Yan; Zong-Kun Shi; Jin-Ji Yang
Efficacy and Safety of Atezolizumab Plus Bevacizumab in Patients With Advanced NSCLC Who Received Pretreatment With EGFR-TKIs (ML41256): A Multicenter, Prospective, Single-Arm, Phase 2 Trial

阿特珠单抗联合贝伐珠单抗在经表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKIs）预治疗的晚期非小细胞肺癌患者中的有效性与安全性（ML41256）：一项多中心、前瞻性、单臂、Ⅱ期临床试验

CANCER MEDICINE
IF3.1
2025-12-150
OAAI
Fang, Wenfeng; Fang, Jian; Tian, Panwen; Fan, Yun; Yu, Qitao; Zhang, Xiaochun; Wang, Zhehai; Liu, Xiaoyuan; Shi, Yanjun; Zhang, Li
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies

替利珠单抗联合西达维替尼或安洛替尼作为广泛期小细胞肺癌的维持治疗：两项前瞻性II期研究的结果

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2025-11-010
OA
Yu, Sizhe; Li, Hui; Lu, Hongyang; Huang, Zhiyu; Chen, Kaiyan; Xu, Yanjun; Gong, Lei; Xie, Fajun; Qin, Jing; Yu, Xinmin; Zhao, Jun; Lou, Guangyuan; Wang, Wenxian; Gu, Cuiping; Han, Na; Xu, Xiaoling; Shao, Lan; Fan, Yun
Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials

Sacituzumab tirumotecan在有无EGFR突变晚期非小细胞肺癌中的研究：Ⅰ/Ⅱ期和Ⅱ期临床试验

NATURE MEDICINE
IF50
2025-04-100
PRE
Zhao, Shen; Cheng, Ying; Wang, Qiming; Li, Xingya; Liao, Jun; Rodon, Jordi; Meng, Xiangjiao; Luo, Yongzhong; Chen, Zhendong; Wang, Wei; Yi, Tienan; Li, Yongsheng; Yin, Yongmei; Xu, Huiting; Yu, Guohua; Mi, Yanjun; Fan, Yun; Wainberg, Zev A.; Wang, Xiang; Su, Cuiyun; Yu, Qitao; Lai, Shuzhen; Sun, Longhua; Zhuang, Wu; Wang, Xian; Yang, Jiacheng; Li, Yaling; Ge, Junyou; Li, Jin; Zhang, Li
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001)

一项安罗替尼联合EGFR-TKIs治疗EGFR-TKIs治疗后出现渐进性、寡性或潜在性进展的晚期非小细胞肺癌的II期临床试验（CTONG-1803/ALTER-L001）。

JOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
2025-01-054
OA
Chen, Hua-Jun; Tu, Hai-Yan; Hu, Yanping; Fan, Yun; Wu, Guowu; Cang, Shundong; Yang, Yi; Yang, Nong; Ma, Rui; Jin, Gaowa; Xu, Ximing; Liu, Anwen; Tang, Shubin; Cheng, Ying; Yu, Yan; Xu, Chong-Rui; Zhou, Qing; Wu, Yi-Long
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial

度伐利尤单抗联合化疗用于晚期非小细胞肺癌的一线治疗（CHOICE-01）：一项随机、双盲、III期试验的最终总生存期及生物标志物探索

Signal Transduction and Targeted Therapy
IF52.7
2024-12-240
OAAI
Jia Zhong; Kailun Fei; Lin Wu; Baolan Li; Zhijie Wang; Ying Cheng; Xiaoling Li; Xicheng Wang; Liang Han; Xiaohong Wu; Yun Fan; Yan Yu; Dongqing Lv; Jianhua Shi; Jianjin Huang; Shaozhang Zhou; Baohui Han; Guogui Sun; Qisen Guo; Youxin Ji; Xiaoli Zhu; Sheng Hu; Wei Zhang; Qiming Wang; Yuming Jia; Ziping Wang; Yong Song; Jingxun Wu; Meiqi Shi; Xingya Li; Zhigang Han; Yunpeng Liu; Zhuang Yu; An-Wen Liu; Xiuwen Wang; Caicun Zhou; Diansheng Zhong; Liyun Miao; Zhihong Zhang; Hui Zhao; Jun Yang; Dong Wang; Yingyi Wang; Qiang Li; Xiaodong Zhang; Mei Ji; Zhenzhou Yang; Jiuwei Cui; Beili Gao; Buhai Wang; Hu Liu; Lei Nie; Mei He; Shi Jin; Wei Gu; Yongqian Shu; Tong Zhou; Jian Feng; Xinmei Yang; Cheng Huang; Bo Zhu; Yu Yao; Sheng Yao; Jianjun Yu; Shang li Cai; Yiran Cai; Jiachen Xu; Wei Zhuang; Xianmin Luo; Jianchun Duan; Jie Wang
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm open-label, multicentre, phase 2 trial
LANCET RESPIRATORY MEDICINE
IF32.8
2024-03-0119
PRE
Wang, Mengzhao; Fan, Yun; Sun, Meili; Wang, Yongsheng; Zhao, Yanqiu; Jin, Bo; Hu, Ying; Han, Zhigang; Song, Xia; Liu, Anwen; Tang, Kejing; Ding, Cuimin; Liang, Li; Wu, Lin; Gao, Junzhen; Wang, Jianghong; Cheng, Ying; Zhou, Jianying; He, Yong; Dong, Xiaorong; Yao, Yu; Yu, Yan; Wang, Huijie; Sun, Si; Huang, Jianan; Fang, Jian; Li, Wen; Wang, Lin; Ren, Xiubao; Zhou, Chengzhi; Hu, Yanping; Zhao, Dahai; Yang, Runxiang; Xu, Fei; Huang, Yijiang; Pan, Yueyin; Cui, Jiuwei; Xu, Yan; Yang, Zhenfan; Shi, Yuankai
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
CANCER COMMUNICATIONS
IF24.9
2024-02-291
OAAI
Zheng, Jing; Wang, Tao; Yang, Yunpeng; Huang, Jie; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wang, Huijie; Cang, Shundong; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Selvaggi, Giovanni; Wang, Yang; Xiao, Shanshan; Wang, Qian; Shen, Zhilin; Zhou, Jianya; Zhou, Jianying; Zhang, Li

研究方向

暂未获取到该数据
K
Kaiyan Chen
H 指数:21论文数:111被引数:1,340
Z
Zhiyu Huang
H 指数:18论文数:68被引数:811
J
Jun Zhao
H 指数:44论文数:475被引数:1.0万
Y
Yanjun Xu
H 指数:31论文数:177被引数:4,377
C
Chengzhi Zhou
H 指数:42论文数:336被引数:6,010
李
李辉
H 指数:28论文数:259被引数:2,702
L
Lin Wu
H 指数:59论文数:473被引数:1.7万
J
Jun‐Fang Lin
H 指数:29论文数:168被引数:2,886
Chen Yunfei 封面图
Chen Yunfei
H 指数:63论文数:792被引数:1.5万
程
程颖
H 指数:84论文数:1,042被引数:4.5万